Liqiang Derek Tou
Dr. Tou’s life science experience has spanned over 20 years as a research and clinical doctor, healthcare executive, entrepreneur, and venture capitalist.
As a serial entrepreneur, Liqiang Derek Tou founded his first startup MandarinArk right after he graduated from Babson College. Subsequently he founded several other startups including SAMA which becomes one of the largest communities for Sino-American medical and pharmaceutical executives in the US. Prior to that Dr. Tou has over 8 years of experience in drug R&D at Novartis and Takeda-Millennium Pharmaceuticals. In both companies, Dr. Tou was a lead scientist and directly participated in several stages of the drug development from early discovery, IND filing through phase I clinical development.
Dr. Tou currently serves as the President of SAMA and is very active in conference organization, fund raising and building a bridge between China and the US for technology exchange. Dr. Tou has been invited as the high talent ambassador for Zhejiang and Nanjing provincial government and has performed the business development role for many big pharmaceutical companies such as Sincere. He has also been invited as part-time investment partner for two VC funds Cg Capital and Dianliang Capital.
Dr. Tou is fully dedicated to bringing his expertise and years of experience to the growth and success of EarthHunt Trading Company, LLC and its International Private Equity Investment Fund.
Dr. Tou obtained his MD from Zhejiang University(1991), Ph.D. from Peking University(1999), and MBA from Babson College(2011). He conducted his postdoctoral training at Dana-Farber Cancer Institute and Harvard Medical School (1999-2004). Prior to that Dr. Tou had over 10 years of clinical experience as a urological surgeon. Dr. Tou has authored or co-authored of 15publications in peer-reviewed journals and has been an invited speaker for many international conferences.